| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 22.93 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Gynecologic cancers account for 10–15 % of
female malignancies, but the genital organs
may also be affected in pelvic irradiation of
other organs and in systemic treatment.
Depending on cancer type and stage, surgery,
radiotherapy, and chemotherapy are treatment
options. Advances in therapy result in
markedly improved survival rates in pelvic
malignancies. In these patients treatmentrelated
side effects are more common than
recurrence, but their differentiation may be
challenging. This is why it is pivotal that the
radiologist is aware of the type of treatment and
the spectrum of normal posttreatment fi ndings,
pitfalls, and complications. Postirradiation
sequelae may complicate the early phase but
may also occur with a latency of many years.
Side effects of targeted agents differ from
those of classical cytotoxic agents, and particularly
in the latter ovarian function may be
impaired.
Description
Keywords
Citation
Rosemarie Forstner; Teresa Margarida Cunha. Female Pelvis: Genital Organs, In Imaging of Complications and Toxicity Following Tumor Therapy, 215-230, ISBN: 978-3-319-12841-2. Berlin, Heidelberg: Springer International Publishing, 2015.
Publisher
Springer International Publishing